EBS - Emergent Biosolutions Q1 2021 Earnings Preview
Emergent Biosolutions (NYSE:EBS) is scheduled to announce Q1 earnings results on Thursday, April 29th, after market close.The consensus EPS Estimate is $1.17 and the consensus Revenue Estimate is $359.69M (+86.9% Y/Y).Over the last 2 years, EBS has beaten EPS estimates 88% of the time and has beaten revenue estimates 50% of the time.Over the last 3 months, EPS estimates have seen 0 upward revisions and 5 downward. Revenue estimates have seen 0 upward revisions and 5 downward.
For further details see:
Emergent Biosolutions Q1 2021 Earnings Preview